A151216- Adjuvant Lung Cancer Enrichment Marker Identification And Sequencing Trial (Alchemist)
Posted Date: May 15, 2019
- Investigator: Emily Daugherty
- Specialties: Cancer, Lung Cancer, Oncology
- Type of Study: Drug
The purpose of this research study is to examine lung cancer patients, surgically removed tumors for certain genetic changes, and to possibly refer these patients to a treatment study with drugs that may specifically target tumors that have these genetic changes.
Criteria:
To Be Eligible: Must Have Lung Cancer Tumor Which Has Already Been Surgically Removed, Age 18 Or Older, No Prior Advanced/Metastatic Cancer Within 5 Years, Nonpregnant/Breastfeeding
Keywords:
Cancer, Lung, Surgery, A151216, Marker
For More Information:
Uc Cancer Center
513-584-7698
cancer@uchealth.com